Ajay Damani

Chief Executive Officer

Ajay Damani is Chief Executive Officer and a member of the Board of Directors of CoreRx since October 2021.  Ajay brings over 20 years of experience in the life sciences industry across business development and marketing, M&A and licensing, and product development.  Prior to joining CoreRx, Ajay led the Pharmaceutical Technologies business unit at Adare Pharmaceuticals, and was a member of the executive leadership team.  Previously, Ajay led the Global Pharmaceutical Business Development organization at Capsugel, and led commercial integration efforts once the company was acquired by Lonza.  Ajay started his career as a management consultant in New York City at Marakon Associates and Booz & Co.  His passion for product development was influenced by his experiences in R&D organizations at Roche in Nutley, NJ and Merck Research Laboratories in Rahway, NJ.

Ajay enjoys working in the global business environment and values world culture and perspective.  He is known for his ability to find creative ways to create business relationships, and for his enthusiasm to serve customers.  He is a champion of diversity & inclusion, and has a reputation for building world-class teams.

Ajay holds dual degrees from the University of Pennsylvania’s School of Engineering and Applied Science and the Wharton School of Business.

Bill Reid

Executive Director and Chief Operating Officer

Bill Reid began his career as a quality control chemist at R.P. Scherer and then moved on as an analytical chemist to Bausch & Lomb developing methods to characterize nasal products.  His work there played a critical role with in-vitro bioequivalence studies which resulted in some of the first ANDA approvals for nasal products. Bill moved on from there to join MDS Pharma Services where he initially served an analytical chemist with a focus on characterization testing across a number dosage forms. He later moved into project management, where he established a strong track record of consistently delivering on projects with significant challenges and tight time lines. His proven team leadership and attention to detail resulted in great customer feedback.

Bill holds a B.S. degree in Chemistry from Delaware Valley College in Doylestown, PA.


Bob Berg

Chief Financial Officer

Mr. Berg is a highly accomplished CFO with over 35 years of experience in all areas of business and personnel management with private and public companies.

Prior to joining CoreRx, Bob served in various executive roles with companies including West-Ward Pharmaceuticals, Boehringer Ingelheim, and the Siemon Company. He has also been a guest teacher and speaker for healthcare economics at the Miami University (Oxford Ohio).

Mr. Berg holds an MBA in Business Administration and Finance from the University of New Haven, and a Bachelor of Arts, Economics and Business Studies from Assumption College.

Janice Cacace, Ph.D.

Senior Director of Formulation Development

Dr. Janice Cacace’s career has spanned over 30 years in the pharmaceutical industry in the areas of formulation, product development, consulting and academia.

She has held management level positions involved in pharmaceutical product development for 15 years, at Sancilio and Company, Azopharma and Ivax. Her experience covers a wide range of dosage forms and product types. These include tablets, capsules, spray-dried dispersions, wet and dry granulations, soft gelatin capsules, oral liquids, topicals, injectables, medical foods, and covers both generic and new chemical entities.

Dr. Cacace holds a Bachelor of Science Degree in Pharmacy from Purdue University, and a Doctor of Philosophy in Pharmaceutics from the University of Florida.

Eric Primelles-Perez

Director of Analytical

Eric Primelles-Perez has held management level positions in analytical development of pharmaceutical products for nearly a decade at Wyeth, Pfizer and Nephron Pharmaceuticals. His experience covers a wide range of dosage forms and product types and includes:  tablets, capsules, soft gelatin capsules, oral liquids, inhalation solutions and suspensions, ophthalmic, injectables, dietary supplements, nutritionals, and covers both generic and new chemical entities.

 Eric holds a Bachelor of Science Degree in Chemistry from University of Las Villas, Cuba. He attended the Doctoral Program in Science (Chemistry), University of Las Villas, Cuba.

Hank Nowak

Executive Director and Head of Global Business Development

Hank Nowak has over 30 years experience in the pharmaceutical industry across R&D, Licensing, Account Management, Marketing and Business Development functions. Initially a research scientist at Bristol-Myers Squibb, he has spent the majority of his career in commercial leadership roles with service organizations such as Banner Pharmacaps, DSM, Patheon, Metabolon and Pharmaceutics International.

Hank holds a B.S. degree in Biology and Mathematics from Fairfield University, as well as advanced science and business degrees from Wesleyan University and the University of Hartford (CT), respectively.

Christy Tobias

Head of Quality

Christy Tobias brings nearly 30 years of experience in the pharmaceutical industry with an extensive background in Quality Management Systems. Christy began her career at Mylan Pharmaceuticals where she worked for over 20 years holding various management level positions of progressively increasing levels of responsibility across the globe. Christy specializes in the development and implementation of Quality systems and Global Quality policies. She has a proven track record of leadership, and creating a harmonized approach to Quality Management.

Bruce Bryan

Executive Director, Head of San Rafael site

Bruce Bryan brings 25 years of experience in the pharmaceutical and biotechnology industry across Manufacturing, CMC, Project Management and Operations. Bruce has held positions at Genentech, Elan Pharmaceuticals, InterMune, Napo Pharmaceuticals, Alios Biopharma, and Janssen Pharmaceuticals. While at Alios Biopharma, he held multiple roles within the leadership team, helping secure capital and grow the company over 7 years leading to an acquisition by Janssen Pharmaceuticals for $1.75 Billion USD. During his time at Janssen, he helped identify a new site location and was on a core team responsible for building a state-of-the-art 298,000 SF R&D facility to expand presence and capabilities in the San Francisco Bay Area.

Bruce holds a Bachelor of Science Degree in Biological Sciences from California State Polytechnic University, San Luis Obispo, California, and an MBA from University of Atlanta.

Jae Yoo

Senior Director of Product Development

Jae Yoo brings 20 years of experience in product development and CMC having been in scientific leadership roles at companies including Gilead Sciences, Novartis, BioMarin, and Celera. In these organizations, Jae was a key member of the development team of therapeutic programs for small molecule oral dosage forms, antibodies, and in-vitro diagnostics. Jae has a BS from UCLA, PhD from UCSD, and spent time as a postdoctoral fellow at Caltech, all in chemistry.

Ryan McFarlane

Executive Director, Operational Excellence

Ryan brings over 20 years of experience in the pharmaceutical industry and has held roles in Operations, Quality, Science and Technology, Marketing, OPEX and Business Management. Prior to CoreRx, Ryan held leadership roles with well-known CDMOs including Banner Pharmacaps, Patheon and Pii.

Partner with us

When you’re ready to get expertise, flexibility, and reliability with your pharmaceutical formulation project, call us or fill out this form. We’ll be happy to answer your questions, provide a tour of our facilities, and get your project started today.